Archive: 10/11/2019
Babies exposed to TNFi or tofacitinib in utero experience very few serious infections
A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these ...
Nov 10, 2019
Opioid use hospitalization rates increased for patients with common rheumatic diseases
New research findings presented this week at the 2019 ACR/ARP Annual Meeting show an increase in opioid-use disorder (OUD) hospitalizations among patients with five musculoskeletal conditions, trends that healthcare providers, ...
Nov 10, 2019
SLE Medicaid patients have higher 30-day death rate compared to those with diabetes
New research found that the 30-day death rate for Medicaid patients with systemic lupus erythematosus (SLE) who underwent coronary revascularization procedures for cardiovascular disease was double that of patients with diabetes ...
Nov 10, 2019
Ultrasound to guide treatment strategy not beneficial in early RA
According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, a treatment strategy guided by ultrasound information use does not appear to provide better treatment decisions in patients with early ...
Nov 10, 2019
Down syndrome arthropathy diagnosis delayed a year, optimal treatments still unclear
A new study found that patients with Down syndrome arthropathy continue to have an approximate year-long delay in diagnosis from the onset of their symptoms, and that optimal therapy for this condition remains unclear (Abstract ...
Nov 10, 2019
Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis. Additionally, they ...
Nov 10, 2019
Tocilizumab more effective than Rituximab in RA patients with low B-cell levels
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond ...
Nov 10, 2019
Atmospheric and environmental changes impact organ-specific lupus flares
New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a clinic visit and organ-specific lupus flares in patients ...
Nov 10, 2019